V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014286 | 160007012 | 1.66 | 76.5 | Palliative (P) | 2018-05-16 | 2018-06-10 | BENDAMUSTINE + RITUXIMAB | N | N | VIDE | 100796367 |
| 160014287 | 160007013 | 1.73 | 65.5 | Neo-adjuvant (N) | 2018-06-27 | 2018-07-04 | Doxorubicin + Ifosfamide | N | null | TRIAL UNSPECIFIED | 101229864 |
| 160014289 | 160007014 | 1.69 | 105.2 | null | 2016-09-27 | 2016-10-16 | Carboplatin + Paclitaxel (3 weekly) | N | null | CARBOPLATIN + PACLITAXEL | 100788150 |
| 160014290 | 160007015 | 1.75 | 97 | Palliative (P) | 2016-11-08 | 2016-11-08 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | null | DOXORUBICIN + OLARATUMAB | 100345704 |
| 160014293 | 160007016 | 1.76 | 101 | Disease modification (D) | 2019-01-01 | 2019-01-06 | Cisplatin + Pemetrexed | N | N | PACLITAXEL | 101809361 |
| 160014294 | 160007017 | 0 | 18.3 | Palliative (P) | 2019-12-06 | 2019-12-12 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100948277 |
| 160014298 | 160007019 | 1.45 | 89.9 | Curative (C) | 2018-08-22 | 2018-08-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100656297 |
| 160014299 | 160007020 | 1.75 | 95 | Curative (C) | 2019-03-24 | 2019-04-01 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100303795 |
| 160014300 | 160007021 | 1.71 | 72.8 | Palliative (P) | 2018-02-28 | 2018-03-28 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101692421 |
| 160014301 | 160007022 | 1.8 | 77.3 | Palliative (P) | null | 2018-05-01 | Doxorubicin 75mg/m2 | N | N | DOXORUBICIN | 101541449 |
| 160014302 | 160007023 | 1.68 | 91 | Curative (C) | 2019-06-30 | 2019-07-23 | null | N | N | DOXORUBICIN + IFOSFAMIDE | 100095647 |
| 160014305 | 160007024 | 1.59 | 65 | 03 | 2019-05-15 | 2019-05-16 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | DOXORUBICIN | 100367787 |
| 160014310 | 160007025 | 1.8 | 84.7 | Palliative (P) | 2017-09-02 | 2017-09-05 | Doxorubicin + Olaratumab | N | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101827780 |
| 160014312 | 160007026 | 1.76 | 54.3 | Palliative (P) | 2019-09-21 | 2019-10-04 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | NOT MATCHED | 101847345 |
| 160014314 | 160007027 | 1.86 | 92.4 | null | 2017-09-09 | 2017-10-03 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 100974464 |
| 160014315 | 160007028 | 0 | 48.5 | Palliative (P) | 2015-07-30 | 2015-08-10 | PEMBROLIZUMAB | 01 | N | STS NON-RHABDO EPSSG 2005 IFOS DOX | 100509895 |
| 160014316 | 160007029 | 1.73 | 70 | Neo-adjuvant (N) | null | 2016-06-30 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101241045 |
| 160014319 | 160007030 | 1.58 | 53.7 | Adjuvant (A) | 2016-12-31 | 2017-01-04 | EW EuroEwing 2012 Arm B VDC | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 VAVV | 100165953 |
| 160014320 | 160007031 | 1.71 | 59.4 | Palliative (P) | 2018-05-10 | 2018-05-20 | ETOP 13-18 BEAT-meso Trial | 02 | N | MELPHALAN | 101757558 |
| 160014322 | 160007032 | 1.84 | 56.4 | Neo-adjuvant (N) | 2018-03-02 | 2018-03-12 | Carboplatin + Liposomal Doxorubicin | 02 | N | TRIAL | 100655596 |
| 160014323 | 160007033 | 1.75 | 93.4 | Neo-adjuvant (N) | 2018-01-04 | 2018-01-13 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100826169 |
| 160014325 | 160007034 | 1.7 | 101 | Palliative (P) | 2019-01-10 | 2019-01-10 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100497679 |
| 160014330 | 160007036 | 1.7 | 75 | Curative (C) | 2016-09-11 | 2016-09-12 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100179346 |
| 160014332 | 160007037 | 1.83 | 87.2 | Curative (C) | 2018-03-13 | 2018-03-26 | Cisplatin + Pemetrexed | 02 | N | TRIAL UNSPECIFIED | 101574198 |
| 160014333 | 160007038 | 1.75 | 77.5 | Palliative (P) | 2019-09-27 | 2019-10-03 | Carboplatin AUC 6 - 10 | 02 | N | DOXORUBICIN | 101711201 |
| 160014335 | 160007039 | 1.72 | 96 | Palliative (P) | 2016-08-24 | 2016-08-27 | Bevacizumab 7.5mg/kg | 02 | N | TRIAL UNSPECIFIED | 100789094 |
| 160014342 | 160007040 | 1.71 | 69.6 | Palliative (P) | 2017-03-31 | 2017-04-18 | null | 02 | N | DOCETAXEL + GEMCITABINE | 100665890 |
| 160014343 | 160007041 | 1.78 | 86 | Palliative (P) | 2017-04-22 | 2017-05-13 | Rucaparib | 02 | N | MELPHALAN | 100057058 |
| 160014344 | 160007042 | 1.78 | 48 | Neo-adjuvant (N) | 2016-09-20 | 2016-09-27 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101844700 |
| 160014345 | 160007043 | 1.79 | 70 | Palliative (P) | 2018-04-12 | 2018-04-12 | Cisplatin + Pemetrexed | Y | null | CISPLATIN + PEMETREXED | 101184194 |
| 160014348 | 160007044 | 1.75 | 60 | Palliative (P) | 2017-03-16 | 2017-03-20 | Trial Unspecified | 2 | null | DOXORUBICIN | 100077757 |
| 160014350 | 160007045 | 1.52 | 75 | Neo-adjuvant (N) | 2019-09-27 | 2019-10-09 | Bortezomib + Panobinostat | 02 | N | PACLITAXEL | 100135632 |
| 160014351 | 160007046 | 1.47 | 96.9 | Palliative (P) | 2019-08-18 | 2019-09-01 | Carboplatin AUC 2 - 5 | 2 | N | CARBOPLATIN | 101726321 |
| 160014353 | 160007047 | 1.67 | 85.7 | Palliative (P) | 2016-06-12 | 2016-06-14 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100373638 |
| 160014354 | 160007048 | 1.71 | 61.4 | Palliative (P) | 2018-01-15 | 2018-01-26 | Cisplatin + Pemetrexed | Y | null | CISPLATIN + PEMETREXED | 101316183 |
| 160014355 | 160007049 | 1.6 | 44.4 | Palliative (P) | 2019-03-05 | 2019-03-08 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101814971 |
| 160014359 | 160007050 | null | null | Neo-adjuvant (N) | 2020-06-15 | 2020-06-15 | Carboplatin + Paclitaxel (3 weekly) | 01 | N | CARBOPLATIN + PACLITAXEL | 101034081 |
| 160014363 | 160007051 | 1.76 | 90.4 | null | 2019-12-30 | 2020-01-01 | IVADo | N | N | VINORELBINE | 100430385 |
| 160014364 | 160007052 | 1.88 | 85.4 | Palliative (P) | 2019-10-17 | 2019-10-19 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101295933 |
| 160014366 | 160007053 | 1.74 | 91.65 | Curative (C) | 2019-02-25 | 2019-03-02 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101488092 |
| 160014370 | 160007054 | 1.92 | 81.1 | Curative (C) | 2020-02-08 | 2020-03-05 | NB Low/Interm risk guidelines Carbo/Etop | 01 | null | CISPLATIN + PACLITAXEL | 101754793 |
| 160014373 | 160007055 | 1.77 | 78.8 | 03 | 2019-02-10 | 2019-02-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101243440 |
| 160014375 | 160007056 | 1.84 | 73.1 | Palliative (P) | 2018-03-27 | 2018-04-23 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 100113485 |
| 160014378 | 160007057 | 1.76 | 81.6 | Palliative (P) | 2018-10-21 | 2018-11-14 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101400791 |
| 160014379 | 160007058 | 1.81 | 79 | null | 2018-08-01 | 2018-08-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100411602 |
| 160014380 | 160007059 | 1.6 | 65.6 | Neo-adjuvant (N) | 2019-08-03 | 2019-08-08 | PACLITAXEL | 02 | N | DOXORUBICIN | 100192792 |
| 160014381 | 160007060 | 1.77 | 83 | null | 2019-10-13 | 2019-10-18 | Doxorubicin 75mg/m2 | 2 | N | DOXORUBICIN | 100130105 |
| 160014382 | 160007061 | 1.7 | 77 | Palliative (P) | 2018-08-24 | 2018-08-24 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101209098 |
| 160014387 | 160007062 | 1.72 | 78 | 03 | 2019-09-01 | 2019-09-12 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101118890 |
| 160014388 | 160007063 | null | 67.7 | 03 | 2021-06-18 | 2021-07-04 | Doxorubicin + Olaratumab | 02 | null | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100921243 |